We value your privacy

We use cookies to analyze site usage and improve your experience. You can accept all, reject non-essential, or customize. See our Privacy Policy.

HRT · 5 min read

Choosing between patches, pills, gels, and creams: HRT delivery explained

By Kevin Wolfe, Founder & CEO

Reviewed by Kindr Health Clinical Team

Published · Updated

How estrogen is delivered changes how it behaves. Here is how to choose with your provider.

For most patients, transdermal estrogen (patch, gel, or cream) is preferred over oral estrogen — it bypasses the liver and is associated with a lower risk of blood clots.

Quick comparison

  • Patch — twice-weekly application, steady delivery, easy to forget about
  • Gel — daily application, flexible dosing
  • Cream — daily application, often used for vaginal symptoms
  • Oral — easy but bypassed by liver; higher clot risk than transdermal

Sources

Medically reviewed by Kindr Health Clinical Team
Last updated: May 10, 2026

More on hrt basics

Continue across the Kindr entity graph

Related evidence, peptides, and clinical tools on the same topic.

This content is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Keep reading

Research

Who shouldn't take hormone therapy? Contraindications, gray areas, and your non-hormonal options.

A recent conference presentation found that hormone therapy prescribing despite a documented contraindication is rising in primary care. Here's what current FDA labels list as contraindications, where an individualized discussion comes in, and which nonhormonal options a major guideline suggests.

Research

Is there an age limit on hormone therapy? Timing, the 10-year window, and HT after 60 and 65.

A SWAN analysis and current FDA and ACOG guidance frame hormone therapy around timing and individual history, not a single age cutoff. Here's what that means for starting, continuing after 60 or 65, and what to ask a clinician.

Research

Strong through menopause: why muscle matters, especially if you're on a GLP-1

A trial of 120 midlife adults on tirzepatide found that lifting three times a week reduced lean-tissue loss and raised strength, with similar weight loss. Here's what that means if you're navigating menopause, and what to discuss with your clinician before you start.

Explore your next step

Kindr Care is being updated, and the exact clinical process will depend on the current care pathway.

Explore care options →